Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions

Jack Wilkinson, Calvin Heal, George A Antoniou, Ella Flemyng, Zarko Alfirevic, Alison Avenell, Virginia Barbour, Nicholas J L Brown, John Carlisle, Mike Clarke, Patrick Dicker, Jo Dumville, Andrew Grey, Steph Grohmann, Lyle C Gurrin, Jill A Hayden, James Heathers, Kylie E Hunter, Toby Lasserson, Emily LamSarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz-Katz, Ben W Mol, Neil E O' Connell, Lisa Parker, Barbara K Redman, Anna Lene Seidler, Kyle A Sheldrick, Emma Sydenham, David J Torgerson, Madelon van Wely, Rui Wang, Lisa Bero, Jamie J Kirkham

Research output: Contribution to journalArticleAcademic

Abstract

INTRODUCTION: Randomised controlled trials (RCTs) inform healthcare decisions. It is now apparent that some published RCTs contain false data and some appear to have been entirely fabricated. Systematic reviews are performed to identify and synthesise all RCTs that have been conducted on a given topic. While it is usual to assess methodological features of the RCTs in the process of undertaking a systematic review, it is not usual to consider whether the RCTs contain false data. Studies containing false data therefore go unnoticed and contribute to systematic review conclusions. The INSPECT-SR project will develop a tool to assess the trustworthiness of RCTs in systematic reviews of healthcare related interventions.

METHODS AND ANALYSIS: The INSPECT-SR tool will be developed using expert consensus in combination with empirical evidence, over five stages: 1) a survey of experts to assemble a comprehensive list of checks for detecting problematic RCTs, 2) an evaluation of the feasibility and impact of applying the checks to systematic reviews, 3) a Delphi survey to determine which of the checks are supported by expert consensus, culminating in 4) a consensus meeting to select checks to be included in a draft tool and to determine its format, 5) prospective testing of the draft tool in the production of new health systematic reviews, to allow refinement based on user feedback. We anticipate that the INSPECT-SR tool will help researchers to identify problematic studies, and will help patients by protecting them from the influence of false data on their healthcare.

Original languageEnglish
JournalmedRxiv
DOIs
Publication statusPublished - 13 Nov 2023

Cite this